INHIBITION OF TOPOISOMERASE-II BY ICRF-193, THE MESO ISOMER OF 2,3-BIS(2,6-DIOXOPIPERAZIN-4-YL)BUTANE - CRITICAL DEPENDENCE ON 2,3-BUTANEDIYL LINKER ABSOLUTE-CONFIGURATION
Rm. Snapka et al., INHIBITION OF TOPOISOMERASE-II BY ICRF-193, THE MESO ISOMER OF 2,3-BIS(2,6-DIOXOPIPERAZIN-4-YL)BUTANE - CRITICAL DEPENDENCE ON 2,3-BUTANEDIYL LINKER ABSOLUTE-CONFIGURATION, Biochemical pharmacology, 52(4), 1996, pp. 543-549
The bis(2,6-dioxopiperazine)s are a structurally and mechanistically u
nique class of topoisomerase II inhibitors that do not bind DNA and th
at do not stabilize topoisomerase II-DNA strand passing intermediates
(''cleavable complexes''). The most effective topoisomerase II inhibit
or in the bis(2,6-dioxopiperazine) series is ICRF-193 (meso or S, R*
isomer), with a meso 2,3-butanediyl linker connecting the dioxopiperaz
ine rings. The two enantiomeric diastereomers, (R,R) and (S,S), of ICR
F-193 possessing the two optically active 2,3-butanediyl linkers have
been prepared from their respective optically pure 2,4-diaminobutanes
via 2,3-diaminobutane-N,N,N',N'-tetraacetic acid, esterification, and
imide formation. Both in vivo and in vitro assays for catalytic inhibi
tion of topoisomerase II were employed to show that the (S,S)- and (R,
R)-isomers are almost inactive as topoisomerase II inhibitors. The dat
a indicate that the meso stereo-chemistry of the alkanediyl linker is
crucial for activity and provides additional evidence that the cytotox
icity of the bis(2,6-dioxopiperazine)s is due to their ability to inhi
bit topoisomerase II.